207 related articles for article (PubMed ID: 7693996)
1. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells.
Leithäuser F; Dhein J; Mechtersheimer G; Koretz K; Brüderlein S; Henne C; Schmidt A; Debatin KM; Krammer PH; Möller P
Lab Invest; 1993 Oct; 69(4):415-29. PubMed ID: 7693996
[TBL] [Abstract][Full Text] [Related]
2. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
[TBL] [Abstract][Full Text] [Related]
3. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
[TBL] [Abstract][Full Text] [Related]
4. Cloning and expression of murine CD27: comparison with 4-1BB, another lymphocyte-specific member of the nerve growth factor receptor family.
Gravestein LA; Blom B; Nolten LA; de Vries E; van der Horst G; Ossendorp F; Borst J; Loenen WA
Eur J Immunol; 1993 Apr; 23(4):943-50. PubMed ID: 8384562
[TBL] [Abstract][Full Text] [Related]
5. Fas (APO-1, CD95) receptor expression and new options for immunotherapy in childhood medulloblastomas.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1999; 19(4B):3293-314. PubMed ID: 10652626
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of APO-1/Fas(CD95)-mediated apoptosis in tolerance and AIDS.
Dhein J; Walczak H; Westendorp MO; Bäumler C; Stricker K; Frank R; Debatin KM; Krammer PH
Behring Inst Mitt; 1995 Jun; (96):13-20. PubMed ID: 7575348
[TBL] [Abstract][Full Text] [Related]
7. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
Heinisch IV; Bizer C; Volgger W; Simon HU
J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
[TBL] [Abstract][Full Text] [Related]
8. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
9. Paneth cells express high levels of CD95 ligand transcripts: a unique property among gastrointestinal epithelia.
Möller P; Walczak H; Reidl S; Sträter J; Krammer PH
Am J Pathol; 1996 Jul; 149(1):9-13. PubMed ID: 8686766
[TBL] [Abstract][Full Text] [Related]
10. Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues.
Fanburg-Smith JC; Miettinen M
Hum Pathol; 2001 Sep; 32(9):976-83. PubMed ID: 11567228
[TBL] [Abstract][Full Text] [Related]
11. Induction of Fas ligand (CD95L) by the toxic mistletoe lectins in human lymphocytes.
Büssing A; Stein GM; Pfüller U; Schietzel M
Anticancer Res; 1999; 19(3A):1785-90. PubMed ID: 10470116
[TBL] [Abstract][Full Text] [Related]
12. The role of apoptosis in normal ontogenesis and solid human neoplasms.
Kaiser HE; Bodey B
In Vivo; 2000; 14(6):789-803. PubMed ID: 11204498
[TBL] [Abstract][Full Text] [Related]
13. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.
Griffith TS; Fialkov JM; Scott DL; Azuhata T; Williams RD; Wall NR; Altieri DC; Sandler AD
Cancer Res; 2002 Jun; 62(11):3093-9. PubMed ID: 12036919
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases.
Mariani SM; Matiba B; Bäumler C; Krammer PH
Eur J Immunol; 1995 Aug; 25(8):2303-7. PubMed ID: 7545118
[TBL] [Abstract][Full Text] [Related]
15. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
16. The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family.
Camerini D; Walz G; Loenen WA; Borst J; Seed B
J Immunol; 1991 Nov; 147(9):3165-9. PubMed ID: 1655907
[TBL] [Abstract][Full Text] [Related]
17. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.
Koyama S; Koike N; Adachi S
J Cancer Res Clin Oncol; 2002 Feb; 128(2):73-9. PubMed ID: 11862476
[TBL] [Abstract][Full Text] [Related]
18. Role of 4-1BB in immune responses.
Vinay DS; Kwon BS
Semin Immunol; 1998 Dec; 10(6):481-9. PubMed ID: 9826581
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.
Dong H; Strome SE; Salomao DR; Tamura H; Hirano F; Flies DB; Roche PC; Lu J; Zhu G; Tamada K; Lennon VA; Celis E; Chen L
Nat Med; 2002 Aug; 8(8):793-800. PubMed ID: 12091876
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1.
Nakashima M; Sonoda K; Watanabe T
Nat Med; 1999 Aug; 5(8):938-42. PubMed ID: 10426319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]